Enhancing osteosarcoma outcomes with a new vaccine platform
The purpose of this study is to evaluate the use of a new tumor vaccine platform given in combination with chemotherapy in dogs with osteosarcoma,
Clinical Trials
Evaluation of the effects of velagliflozin in cats with congestive heart failure secondary to hypertrophic cardiomyopathy
Heart disease is a very common problem in cats, with the most common form of feline heart disease being hypertrophic cardiomyopathy.
A multi-center pivotal field study to confirm the effectiveness and safety of verdinexor for the treatment of lymphoma in dogs
Standard treatment of lymphoma involves a 16-week conventional chemotherapy protocol with an 80% response rate for an average of 10 to 12 months.
Treatment of myxomatous mitral valve disease with sTGFBR2
Myxomatous mitral valve disease (MMVD) is a common heart valve disease in dogs where the heart valve becomes thickened as a dog ages, causing leaka
Toceranib therapy in dogs with cancer: monitoring cardiovascular toxicity, biomarkers, and assessing antihypertensive treatments
Palladia is an oral cancer treatment that has been used to treat tumors in dogs for the past 10 years.
Short course amoxicillin for treatment of sporadic bacterial cystitis in dogs
The purpose of the study is to determine the necessary treatment duration for urinary tract infection (UTI) in dogs
Establishing a reference range for postprandial triglyceride concentrations in healthy adult dogs
The purpose of the study is to determine a reference range for post-meal triglyceride concentration in healthy dogs across various body condition s
Dog Aging Project Test of Rapamycin in Aging Dogs (TRIAD)
Rapamycin, a medication that affects both the immune system and metabolism, has been shown to increase the lifespan of mice.
Prevalence of resistant fecal bacteria in dogs and co-carriage with owners after treatment with short-course antimicrobials
Antibiotic resistance in pets is a problem in veterinary medicine.